Tenecteplase contraindications: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Tenecteplase}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== TNKase therapy in patients with acute myocardial infarction is contraindicated in the following situat...")
 
m (Protected "Tenecteplase contraindications": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Tenecteplase#Contraindications]]
{{Tenecteplase}}
{{CMG}}; {{AE}} {{SS}}


==Contraindications==
[[Category: Cardiovascular Drugs]]
TNKase therapy in patients with acute myocardial infarction is contraindicated in the following situations because of an increased risk of bleeding (seeWARNINGS):
[[Category: Drug]]
 
*Active internal bleeding
*History of cerebrovascular accident
*Intracranial or intraspinal surgery or trauma within 2 months
*Intracranial neoplasm, [[arteriovenous malformation]], or [[aneurysm]]
*Known bleeding diathesis
*Severe uncontrolled [[hypertension]]<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TNKASE (TENECTEPLASE) KIT [GENENTECH, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69e391bf-1250-4083-aa60-6aa41c33657f | publisher =  | date =  | accessdate = 6 February 2014 }}</ref>
==References==
 
{{Reflist|2}}
 
[[Category:Thrombolytic drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 17:13, 20 August 2015